Description

Chronically psychotic patients in the maintenance phase of treatment are frequently medication non-adherent and have inadequate community supports; relapse is common.  This learning program will teach participants to identify the multiple barriers to successful maintenance treatment and recovery.  Participants will also learn specific strategies to address these obstacles and maximize the long-term health and stability of chronically psychotic patients.

Learning Objectives

At the end of this educational activity, participants should be able to:

  • Demonstrate the ability to effectively assess treatment adherence during office visits using the ABCs of adherence.

Faculty

  • Oliver Freudenreich, MD
    Director, First Episode and Early Psychosis Program Massachusetts General Hospital
    Associate Professor of Psychiatry, Harvard Medical School
  • Tristan L Gorrindo, MD
    Co-Director, MGH Postgraduate Medical Education
    Instructor in Psychiatry, Harvard Medical School

Target Audience

Psychiatrists, Primary Care Physicians, Nurse Practitioners, and Physician Assistants

CME Information

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of McLean Hospital, Massachusetts General Hospital Academy and Reed Medical Education. McLean Hospital is accredited by the ACCME to provide continuing medical education (CME) for physicians.

Credit Designation
McLean Hospital designates this continuing medical educational activity for a maximum of 1 AMA PRA Category 1 Credits(TM). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty and Provider Disclosure
It is the policy of McLean Hospital that faculty and providers disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s). McLean Hospital has established policies in place that identify and resolve all conflicts of interest prior to this educational activity.

Planners

The following planners of this activity have indicated that neither they nor their families have a significant financial interest or affiliation with the manufacturer of any commercial products or provider of commercial services:

Robert J. Birnbaum, MD, PhD: Planner

John A. Fromson, MD: Planner, reviewer

Anan Nathif, EdM: Planner

Tristan Gorrindo, MD: Planner

Hardware/Software Specifications: 

This internet-based CME activity is best experienced using Internet Explorer 8+, Mozilla Firefox 3+, Safari 4+. This Web site requires that JavaScript and session cookies be enabled. Certain activities may require additional software to view multimedia, presentation, or printable versions of the content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Adobe Acrobat, Microsoft PowerPoint, and Windows Media Player.

Optimal System Configuration:
Flash Player: Adobe Flash Player 10.1+
Browser: Firefox 3+, Internet Explorer 8.0+, Safari 4.0+, or Google Chrome 7.0+
Operating System: Windows XP+ or Mac OS X 10.4+
Internet Connection: 1 Mbps or higher

Minimum Requirements:
Windows PC:
500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Sound Card at least 16-bit; Macromedia Flash Player 10 or higher, audio playback with speakers for programs with video content; Firefox 1.1+, Internet Explorer 7.0+, Safari 1.0+, Google Chrome, or Opera
Macintosh:
Mac OS X 10.3 or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit

Speakers

 

The following speakers and/or planners have reported receiving something of value from a company whose product may be germane to the content of their presentations:

Oliver Freudenreich, MD

Speaking/Honoraria

AstraZeneca, BMS, Janssen, Eli Lilly & Co., and Pfizer.

Advisory/Consulting

Beacon Health Strategies.

 

Last updated: 7/27/2010

 

Tristan L Gorrindo, MD

Dr. Gorrindo has indicated that neither he nor any member of his immediate family has a significant financial interest or affiliation with the manufacturer of a commercial product or provider of a commercial service.

Last updated: 1/5/2012

Supporters

Location

online